Norris Perne & French’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,500
| Closed | -$50K | – | 140 |
|
|
2018
Q1 | $50K | Sell |
10,500
-20,000
| -66% | -$95.2K | 0.01% | 148 |
|
|
2017
Q4 | $102K | Hold |
30,500
| – | – | 0.01% | 149 |
|
|
2017
Q3 | $65K | Hold |
30,500
| – | – | 0.01% | 153 |
|
|
2017
Q2 | $75K | Hold |
30,500
| – | – | 0.01% | 151 |
|
|
2017
Q1 | $70K | Hold |
30,500
| – | – | 0.01% | 154 |
|
|
2016
Q4 | $30K | Hold |
30,500
| – | – | 0.01% | 148 |
|
|
2016
Q3 | $34K | Hold |
30,500
| – | – | 0.01% | 142 |
|
|
2016
Q2 | $45K | Hold |
30,500
| – | – | 0.01% | 137 |
|
|
2016
Q1 | $44K | Hold |
30,500
| – | – | 0.01% | 143 |
|
|
2015
Q4 | $50K | Hold |
30,500
| – | – | 0.01% | 151 |
|
|
2015
Q3 | $71K | Hold |
30,500
| – | – | 0.02% | 145 |
|
|
2015
Q2 | $83K | Hold |
30,500
| – | – | 0.02% | 157 |
|
|
2015
Q1 | $102K | Hold |
30,500
| – | – | 0.02% | 162 |
|
|
2014
Q4 | $106K | Buy |
30,500
+8,500
| +39% | +$29.5K | 0.02% | 161 |
|
|
2014
Q3 | $111K | Buy |
+22,000
| New | +$111K | 0.02% | 163 |
|